NEXUS
-
Regulatory
Misonix Announces CE Mark Approval for Nexus
FARMINGDALE, N.Y., Aug. 12, 2019 (GLOBE NEWSWIRE) — Misonix, Inc. (NASDAQ: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic…
Read More » -
Regulatory
Misonix Receives U.S. FDA Clearance For NEXUS, Its Revolutionary Integrated Ultrasonic Surgical Platform
FARMINGDALE, N.Y., (June 3, 2019) – Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic…
Read More »